Hydroxychloroquine (HCQ) has been implicated in antiviral activity in vitro against severe
acute respiratory syndrome coronavirus 2 (SARS-CoV-2). However, there is still controversy …

ABSTRACT Importance The COVID-19 Pandemic has literally left the world breathless in the
chase for pharmacotherapy. With vaccine and novel drug development in early clinical trials …

The COVID-19 pandemic is showing an exponential growth, mandating an urgent need to
develop an effective treatment. Indeed, to date, a well-established therapy is still lacking. We …

The world is suffering a respiratory pandemic disease caused by a novel coronavirus (2019-
nCoV), commonly known as COVID-19 (coronavirus disease 2019). The Food and Drug …

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) continues to be a threat to
the health of many humans across the world as they confront coronavirus disease 2019 …

Use of Hydroxychloroquine in Patients with COVID-19: A Retrospective Observational Study -
PMC Back to Top Skip to main content NIH NLM Logo Access keys NCBI Homepage MyNCBI …

The review summarizes chloroquine (CQ) and its safer derivative hydroxychloroquine (HCQ)
and its utility in Covid-19. Recently this well-established drug made its way back to the …

Drugs that are specifically efficacious against SARS-CoV-2 have yet to be established.
Chloroquine and hydroxychloroquine have garnered considerable attention for their …

Hydroxychloroquine (HCQ), also known by its trade name Plaquenil®, has been used for
over 50 years as a treatment for malaria, systemic lupus erythematosus, and rheumatoid …

Hydroxychloroquine (HCQ) has shown efficacy against coronavirus disease 2019 (COVID-
19) in some but not all studies. We hypothesized that a systematic review would show HCQ …